Clinical trial
Understanding the Molecular and Genetic Differences Between GCT at the Time of the Initial Diagnosis and at Late Relapse
NCT02679950 is registered in ClinicalTrials.gov with Nasser Hanna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Understanding the Molecular and Genetic Differences Between GCT at the Time of the Initial Diagnosis and at Late Relapse
- Lead sponsor
- Nasser Hanna
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 20, 2015
- Completion date
- April 25, 2017
- Enrollment
- 6 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.